The most common types of viral hepatitis infections are hepatitis A, B, C, and D. Hepatitis A is a short-term infection, but B, C, and D can become chronic, lifelong infections. All four are preventable and treatable.

About 5% of Philadelphia residents have a past or current hepatitis A, B, or C infection. Many people are unaware of their infection.

Diagnostic and clinical tools exist to prevent new hepatitis B, C, and D infections, and to diagnose, treat, and cure (in the case of hepatitis C) existing infections among Philadelphia residents. Many healthcare providers, clinics, and systems actively support vaccination, screening, and treatment of hepatitis B, hepatitis C, and hepatitis D.

The Viral Hepatitis Program works to prevent and to address hepatitis B, C, and D by using trauma-informed, equitable, diversity-driven, culturally competent, and harm reduction-oriented practices. We do this by:

• Measuring their incidence and prevalence in Philadelphia.
• Working with the medical community to improve reporting, clinical, and prevention activities.
• Promoting best practices to ensure equitable access to testing, linkage to care, retention in care, and cure for all individuals who have hepatitis B, C, or D.
• Coordinating case management to reduce and address transmission from pregnant people to babies.
• Providing linkage to resources for those living with hepatitis B, C, or D.

Find out more:

• • Hepatitis B and Hepatitis C in Philadelphia Annual Reports
  • Hepatitis A and B Vaccinating Pharmacies in Philadelphia
  • Hepatitis B and C Treating Providers in Philadelphia
  • Philadelphia's Hepatitis B & Hepatitis C Elimination Plan Community Engagement Executive Summary.